© PR Newswire
13.01.2026
INTS
LISTED
NASDAQ
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities
News Preview
Peer-reviewed clinical validation, strengthened balance sheet, and disciplined execution position the Company for 2026SHELTON, Conn., Jan. 13, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer th...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
ARMP
LISTED
XASE
Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated Staphylococcus aureus Bacteremia
News Preview
FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3studyFirst bacteriophage company to advance a clinical candidate to Phase 3 LOS ANGELES, Jan. 13, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
13.01.2026
AIAI
LISTED
CSE
NetraMark Announces Private Placement Financing
News Preview
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce a non-brokered private placement of up...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
13.01.2026
PTHS
LISTED
XASE
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
News Preview
The minimally dilutive funding will accelerate Pelthos’ highly successful commercialization efforts for its lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3% for the treatment of molluscum contagiosum, two newly acquired FDA approved cutaneous infectious disease products and for working capital and general corporate purposes The minimally dil...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2026
NPCE
LISTED
NASDAQ
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
News Preview
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported preliminary unaudited results for the fourth quarter ended December 31, 2025 with total revenue of approximately $26.6 million, an increase of 24% over the fourth quarter of 2024. RNS revenue is expected to be a...
Themefolio
Profiler
Peergroup
© Newsfile
13.01.2026
CRDL
LISTED
TSX
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
News Preview
Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers actively enrolling patients.Activation of additional top-tier clinical sites in Europe and Canada underway, further accelerating enrollment momentum.Full enrollment expected in Q2 2026.Toronto, Ontario--(Newsfile Corp. - January 13, 2026) -...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
REC
LISTED
EURONEXT
ISTURISA® (osilodrostat) Now Available in Canada for the Treatment of Cushing's Disease
News Preview
ISTURISA® (osilodrostat) is indicated for the treatment of adult patients with Cushing's disease who have persistent or recurrent hypercortisolism after primary pituitary surgery and/or irradiation, or for whom pituitary surgery is not an option.1TORONTO, Jan. 13, 2026 /CNW/ - Recordati Rare Diseases Canada Inc. announced today the Canadian produc...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
LH
LISTED
NYSE
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk
News Preview
Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imagingLabcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancerBURLINGTON, N.C., Jan. 13, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and c...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
ALGS
LISTED
NASDAQ
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
News Preview
Seasoned leader with global commercialization and marketing expertise Seasoned leader with global commercialization and marketing expertise...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
GDTC
LISTED
NASDAQ
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
News Preview
SINGAPORE, Jan. 13, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, inc...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
PCRX
LISTED
NASDAQ
Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
News Preview
-- LG Chem becomes exclusive distributor of EXPAREL -- – Partnership expands patient access to opioid-sparing pain control and advances 5x30 strategy–...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
13.01.2026
45680
LISTED
XJPX
TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
News Preview
The first patient has been dosed in the TROPION-Lung17 phase 3 trial evaluating DATROWAY® (datopotamab deruxtecan) compared to docetaxel in patients with TROP2 NMR positive locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) without actionable genomic alterations previously treated with immunotherapy and platinum-based ch...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
CAH
LISTED
NYSE
Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation
News Preview
Raising Fiscal 2026 Outlook: Cardinal Health is increasing expectations for fiscal year 2026 non-GAAP diluted earnings per share (EPS)1 to at least $10.00, from its prior guidance range of $9.65 to $9.85Accelerating Specialty Growth: The company expects that its Specialty revenues will surpass $50 billion in fiscal 2026, marking a 16% compounded a...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
BDX
LISTED
NYSE
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs
News Preview
Introduces BD Neopak™ Glass Prefillable Syringe production in Columbus, NebraskaFRANKLIN LAKES, N.J., Jan. 13, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its production of prefillable syringes, helping accelerate biologic and...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
BCT
LISTED
TSX
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient
News Preview
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announces the durable and sustained complete resolution of a lung...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
GLAS.A.U
LISTED
NEO
University of California Berkeley and Glass House Collaboration Leads to State-Funded Research on Cannabis Crop Yields
News Preview
LONG BEACH, Calif. and TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., continues to collaborate with the University of California Berkeley thro...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
AVXL
LISTED
NASDAQ
Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease
News Preview
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced its participation as a key industry partner in ACCESS-AD, a major new European initiative designed to accelerate the adoption of innovative diagnostic and therapeutic approaches for Alzheimer’s disease (AD) across rea...
Themefolio
Profiler
Peergroup
© Newsfile
13.01.2026
CHS
LISTED
TSX
Comprehensive Healthcare Systems Inc. Engages RedChip Companies to Lead Investor Relations Efforts
News Preview
Calgary, Alberta--(Newsfile Corp. - January 13, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (OTCQB: CMHSF) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, today announced that it has engaged RedChip Companies ("RedChip") to lead its investor relations and strategic communicatio...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
SGHT
LISTED
NASDAQ
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
News Preview
MENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported select preliminary, unaudited financial hi...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
TMCI
LISTED
NASDAQ
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
News Preview
PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced its preliminary, unaudited fourth quarter and full-year 2025 revenue results...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
KTTA
LISTED
NASDAQ
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines
News Preview
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
CI
LISTED
NYSE
The Cigna Group's Fourth Quarter 2025 Earnings Release Details
News Preview
BLOOMFIELD, Conn., Jan. 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2025 financial results on Thursday, February 5, 2026, and will host a conference call the same day.
Fourt...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
TRAW
LISTED
NASDAQ
Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients
News Preview
IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced Research and Development Authority (BARDA) for inclusion in strategic stockpile...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
KYMR
LISTED
NASDAQ
Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs
News Preview
KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
OCGN
LISTED
NASDAQ
Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data
News Preview
MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast with KOLs and Ocugen executive leadership to discuss data from the first half of patients completi...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2026
ONC
LISTED
NASDAQ
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference
News Preview
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will outline the pillars of its growing global oncology leadership during its presentation today at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
John V. Oyler, Co-Founder, Chairman, and CEO at BeOne, will highlight the Company’s transf...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
RWB
LISTED
CSE
Red White & Bloom Brands Announces Appointment of Michael Di Brina as New Director
News Preview
RWB appoints Michael Di Brina to its Board effective January 12, 2026, and announces the resignation of founding director Michael Marchese...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
ACON
LISTED
NASDAQ
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028
News Preview
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.01.2026
NNVC
LISTED
XASE
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2
News Preview
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, declares that the current severe influenza wave demonstrates the clear need for broad-spectrum antivirals that c...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.01.2026
FWBI
LISTED
NASDAQ
GridAI's Role at the Center of Grid Intelligence Economics
News Preview
BOCA RATON, FL / ACCESS Newswire / January 13, 2026 / Infrastructure narratives are easy to tell. Execution narratives are harder, and far more revealing.Grid intelligence now belongs firmly in the latter category. The underlying logic is no longer speculative. Power demand continues to rise, infrastructure timelines remain stretched, and software-...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
45650
LISTED
XJPX
Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa
News Preview
Tokyo, Japan and Cambridge, UK, 13 January 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Centessa Pharmaceuticals has achieved an early development milestone associated with its investigational, orally administered, highly potent and selective orexin receptor 2 (OX2R) agonist, ORX142, in development for the treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
KDEV
LISTED
STO
The subscription period in Karolinska Development AB (publ)’s rights issue begins today
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.01.2026
LOBE
LISTED
CSE
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
News Preview
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 13, 2026 / Lobe Sciences Ltd. ("Lobe Sciences" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a clinical-stage biopharmaceutical company focused on advancing therapies for diseases with significant unmet medical needs, today announced the appointment of Mr. Nick Kar...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
BSLN
LISTED
SIX
Basilea joins INCATE to support antifungal innovation
News Preview
Allschwil, Switzerland, January 13, 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
KURN
LISTED
SIX
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
News Preview
Kuros to present U.S. IDN approvals, MDR certification and new evidence supporting MagnetOs adoption at Octavian and Baader Bank conferences....
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
ABBV
LISTED
EURONEXT
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans
News Preview
AbbVie will provide low prices in Medicaid, and expand affordable, direct-to-patient offerings for treatments used by millions of Americans through TrumpRx AbbVie will commit $100 billion in U.S. research and development (R&D) and capital investments, including manufacturing, over the next decadeThis three-year agreement provides AbbVie with e...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2026
AGL
LISTED
NYSE
AGL ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of agilon Investors
News Preview
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL) securities during the period of February 26, 2025 through August 2, 2025, inclusive (“the Class Period”).
If you suffered a loss on your agilon investments, you ha...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2026
SLNO
LISTED
NASDAQ
SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.
News Preview
The law firm of Kirby McInerney LLP continues its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
BBNX
LISTED
NASDAQ
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112145401/en/
Faruqi & Faruqi is a leading national sec...
Themefolio
Profiler
Peergroup
© Newsfile
12.01.2026
VIVI
LISTED
CSE
TempraMed Closes C$2.5 Million Fully Subscribed Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce the fully subscribed closing of its previously announced non-brokered p...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TKOMF
LISTED
OTC
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on January 9, 2026, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 4,900 shares of common stock and 6,500 restricted stock units (“RSUs”) to five new employees under Mirum’s 2020 Inducement Plan....
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TVTX
LISTED
NASDAQ
Travere Therapeutics Provides Corporate Update and 2026 Outlook
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects total U.S. net product sales for the fourth quarter of 2025 to be approximately $127 million. For the fiscal year 2025, the Company expects total U.S. net product sales to be approximately $410 million. The Company...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
BBNX
LISTED
NASDAQ
Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BETA BIONICS, INC. (BBNX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A C...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TMO
LISTED
NYSE
Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The effort will leverage the NVIDIA Artificial Intelligence (AI) platform and Thermo Fisher Scientific solutions to progressively increase the automation, ac...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
CRL
LISTED
NYSE
Charles River Laboratories Provides Business Updates
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) today announced two planned acquisitions of K.F. (Cambodia) Ltd. and PathoQuest SAS; the addition of Dr. Namandjé N. Bumpus as Chief Scientific and Innovation Officer; and is also providing an update on recent business trends and a preliminary 2026 outlook at the J.P. Morgan 44th Annual He...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
HQH
LISTED
NYSE
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
News Preview
PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of Dec...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
BDX
LISTED
NYSE
BD To Host Virtual 2026 Annual Meeting of Shareholders
News Preview
FRANKLIN LAKES, N.J., Jan. 12, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2026 Annual Meeting of Shareholders (the "Annual Meeting") on Tuesday, January 27, 2026, at 1:00 p.m. (ET).
As described in the proxy materials for the Annual...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
PACS
LISTED
NYSE
PACS Group, Inc. to Present at Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026, at 5:15 p.m., Pacific Time
News Preview
PACS Group, Inc. (NYSE: PACS) announced today that Jason Murray, Chairman and Chief Executive Officer, and Mark Hancock, Executive Vice President and Interim Chief Financial Officer, will present at the annual J.P. Morgan Healthcare Conference in San Francisco. The presentation audio will be webcast live on Tuesday, January 13, 2026, at 5:15 pm Pa...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
ASRT
LISTED
NASDAQ
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
News Preview
Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with all applicable listing requirements.
As of January 12, 2026, Nasdaq has determined that Assertio has regained compliance with the Minimum...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
RVTY
LISTED
NYSE
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance
News Preview
Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 2026. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief fina...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
ILMN
LISTED
NASDAQ
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
News Preview
SAN DIEGO, Jan. 12, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the fourth quarter and full year 2025 following the close of market on Thursday, February 5, 2026.
On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
BMRN
LISTED
NASDAQ
BioMarin Appoints Arpit Davé Chief Digital and Information Officer
News Preview
Mr. Davé Brings more than 20 Years of Experience in Creating Enterprise Value through Digital Transformation, Information Technology and Artificial Intelligence across the Biopharmaceutical IndustrySAN RAFAEL, Calif., Jan. 12, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced it has appointed Arpit Davé as Executive...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
PLTR
LISTED
NASDAQ
Palantir Announces Date of Fourth Quarter 2025 Earnings Release and Webcast
News Preview
Palantir Technologies Inc. (NASDAQ: PLTR) announced today that results for its fourth quarter and fiscal year ended December 31, 2025 will be released on Monday, February 2, 2026, following the close of U.S. markets. Palantir will host a webcast to discuss its results at 3:00 PM MT / 5:00 PM ET.
A live webcast and replay will be available at inv...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
SEGN
LISTED
TSX
Seegnal's Investor Meet & Greet with Corporate CEO, Mr. Elad Bibi-Aviv
News Preview
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/CALGARY, AB, Jan. 12, 2026 /CNW/ - (TSXV: SEGN), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced that its Chief Executive Officer, Elad Bibi-Aviv, will host two virtual investor meet...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
NHPAP
LISTED
NASDAQ
National Healthcare Properties Announces Appointment of Scott Humphrey to the Board of Directors
News Preview
NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company” or “NHP”) announced today the appointment of Scott Humphrey to the Company’s Board of Directors (the “Board”). Mr. Humphrey will serve as one of NHP’s independent directors and the chair of the Audit Committee, effective January...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
PSNL
LISTED
NASDAQ
Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the early access launch of Real-Time Variant Tracker, a powerful new option added to its ultrasensitive NeXT Personal molecular residual disease (MRD) test designed to detect small traces of circulating tumor DNA (ctDNA) in the blood that represent residual...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
OPCH
LISTED
NASDAQ
Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026
News Preview
BANNOCKBURN, Ill., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, and prel...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
IRON
LISTED
NASDAQ
Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer
News Preview
WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Lisa Amaya Price, MBA as the company’s Chief...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
